SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The picks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Murphy who wrote (3822)2/4/1997 1:12:00 PM
From: Shawn Murphy   of 6124
 
********* TO ALL ********* RE: NEW PICK >>Organogenesis Incorporated (ORG)

ORG- is a LONG term pick (4 to 6 months) I am looking for prices in the near $40 to $50 mark.

quote.yahoo.com
______________________________________________________________________
Organogenesis Inc.

Address: 150 Dan Rd. (map)
Canton, MA 02021
Phone: 617-575-0775
Fax: 617-575-0775
Web Site: --

CEO: Herbert M. Stein
CFO: Curtis W. Rodenhouse
HR: --

Fiscal Year End: December
Sales Year: 1995
Sales ($ millions): 0.6 (latest quarterly financials)
1-Yr. Sales Change: 100.0%

Employees: 99

Ticker Symbol: ORG
Exchange: AMEX

Description:
Organogenesis, Inc.
designs, develops, and
manufactures medical
therapeutics using living
human cells and natural
connective tissue
components. Tissue
engineering focuses on
developing specialized
biomaterials and cellular
constructs to assist,
repair, regenerate, or
replace diseased or
damaged organs. The
company is using its
technology in the
following areas: wound
care, cardiovascular,
general surgery, urology,
and orthopedics.
Organogenesis's tissue
engineered products,
such as GRAFTSKIN and
GRAFTARTERY, are
designed to promote the
establishment and growth
of the body's natural
healing process by
stimulating the growth of
new tissues that maintain,
restore, or improve
biological function.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext